Martin Pass

Title: Martin Pass - Innovator in Thrombin Inhibitors

Introduction

Martin Pass is a notable inventor based in Stevenage, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of thrombin inhibitors. With a total of 2 patents to his name, his work has the potential to impact clinical treatments significantly.

Latest Patents

One of Martin Pass's latest patents involves benzamide derivatives as thrombin inhibitors. This invention relates to a novel class of amide derivatives that act as thrombin inhibitors, described by a specific formula. The compounds include various groups that can be substituted, providing a range of options for therapeutic applications. His second patent focuses on benzofuran derivatives, which also includes physiologically acceptable salts and esters, further expanding the potential for medical use.

Career Highlights

Martin Pass is associated with Glaxo Group Limited, a prominent company in the pharmaceutical industry. His work at Glaxo has allowed him to explore innovative solutions in drug development, particularly in the area of thrombin inhibition.

Collaborations

Throughout his career, Martin has collaborated with notable colleagues, including Nigel Stephen Watson and Vipulkumar Kantibhai Patel. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Martin Pass is a distinguished inventor whose work in thrombin inhibitors showcases his innovative spirit and dedication to improving medical treatments. His contributions to the pharmaceutical field are noteworthy and have the potential to benefit many patients in need.